Literature DB >> 25236654

Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders.

Tatiana Koudriavtseva1, Domenico Plantone, Rosaria Renna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25236654     DOI： 10.1007/s00415-014-7506-5

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  16 in total

1.  Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder.

Authors:  Youming long; Yihua He; Yangbo Zheng; Mengyu Chen; Bin Zhang; Cong Gao
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

2.  High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory-thrombotic processes.

Authors:  Tatiana Koudriavtseva; Giovanna D'Agosto; Chiara Mandoj; Isabella Sperduti; Paola Cordiali-Fei
Journal:  Neurol Sci       Date:  2014-05-22       Impact factor: 3.307

3.  Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?

Authors:  M Renaud; J Aupy; B Uring-Lambert; J-B Chanson; N Collongues; F Blanc; J De Sèze
Journal:  Eur J Neurol       Date:  2014-04-02       Impact factor: 6.089

4.  Rheological and fibrinolytic findings in multiple sclerosis.

Authors:  A Brunetti; G L Ricchieri; G M Patrassi; A Girolami; B Tavolato
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

5.  Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis.

Authors:  Lei Wu; Dehui Huang; Yang Yang; Weiping Wu
Journal:  Eur Neurol       Date:  2014-07-01       Impact factor: 1.710

6.  Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.

Authors:  Neeta Garg; Robert Zivadinov; Murali Ramanathan; Irene Vasiliu; Jaclyn Locke; Kelly Watts; Jordan Lema; Jyotsna Rajeswary; Frederick E Munschauer; Julian Ambrus; Bianca Weinstock-Guttman
Journal:  J Neuroimmunol       Date:  2007-05-18       Impact factor: 3.478

7.  Normal plasma antithrombin activity in patients with relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  Marilza Campos-de-Magalhães; Adilson José de Almeida; Regina Maria Papaiz-Alvarenga; Telma Gadelha; Carlos Alberto Morais-de-Sá; Soniza Vieira Alves-Leon
Journal:  Clin Neurol Neurosurg       Date:  2009-01-25       Impact factor: 1.876

8.  Coagulation status and biochemical and inflammatory markers in multiple sclerosis.

Authors:  Fehime B Aksungar; Aynur E Topkaya; Zeynep Yildiz; Sevki Sahin; Ulku Turk
Journal:  J Clin Neurosci       Date:  2008-02-06       Impact factor: 1.961

9.  Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study.

Authors:  Carlos J Bidot; Lawrence L Horstman; Wenche Jy; Joaquin J Jimenez; Carlos Bidot; Yeon S Ahn; J Steven Alexander; Eduardo Gonzalez-Toledo; Roger E Kelley; Alireza Minagar
Journal:  BMC Neurol       Date:  2007-10-18       Impact factor: 2.474

Review 10.  Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.

Authors:  Tatiana Koudriavtseva
Journal:  Front Neurol       Date:  2014-07-07       Impact factor: 4.003
View more
  5 in total

Review 1.  Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.

Authors:  Tatiana Koudriavtseva; Rosaria Renna; Domenico Plantone; Caterina Mainero
Journal:  Front Neurol       Date:  2015-03-24       Impact factor: 4.003

2.  Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations.

Authors:  Tatiana Koudriavtseva; Domenico Plantone
Journal:  Front Neurol       Date:  2016-12-05       Impact factor: 4.003

Review 3.  A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis.

Authors:  Domenico Plantone; Matilde Inglese; Marco Salvetti; Tatiana Koudriavtseva
Journal:  Front Neurol       Date:  2019-01-14       Impact factor: 4.003

4.  Quantified CSF antibody reactivity against myelin in multiple sclerosis.

Authors:  Xingwen Sun; Mostafa Bakhti; Dirk Fitzner; Mareike Schnaars; Niels Kruse; Ünal Coskun; Christiane Kremser; Klaus Willecke; Ludwig Kappos; Jens Kuhle; Mikael Simons
Journal:  Ann Clin Transl Neurol       Date:  2015-11-09       Impact factor: 4.511

5.  Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis.

Authors:  Tatiana Koudriavtseva; Annunziata Stefanile; Marco Fiorelli; Caterina Lapucci; Svetlana Lorenzano; Silvana Zannino; Laura Conti; Giovanna D'Agosto; Fulvia Pimpinelli; Enea Gino Di Domenico; Chiara Mandoj; Diana Giannarelli; Sara Donzelli; Giovanni Blandino; Marco Salvetti; Matilde Inglese
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.